FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127168048> ?p ?o ?g. }

• W3127168048 abstract "SummarySézary syndrome (SS) is a rare, leukemic type of cutaneous T-cell lymphoma (CTCL), for which extracorporeal photopheresis (ECP) is a first-line therapy. Reliable biomarkers to objectively monitor the response to ECP in patients with SS are missing. We examined the quantitative and qualitative impact of ECP on natural killer (NK) cell activity in SS patients, and especially their functional ability for antibody-dependent cell-mediated cytotoxicity (ADCC). Further, we addressed the question whether the magnitude of the effect on ADCC can be associated with the anti-cancer efficacy of ECP in SS patients. We assessed numbers of NK cells, ADCC activity, and treatment response based on blood tumor staging in a cohort of 13 SS patients (8 women, 5 men) treated with ECP as a first-line therapy. Blood samples were collected before treatment start and after an average of 9 months of uninterrupted ECP treatment. NK cell numbers were reduced in SS patients compared to healthy individuals and showed a tendency of recovery after long-term ECP treatment, independent of the clinical response to treatment. Patients with marginal increase (≤1.5 AU-fold) or lack of increase in ADCC activity failed to respond clinically to treatment, while patients with an increased ADCC activity showed a reduction in blood tumor burden. NK-mediated ADCC is selectively enhanced and might be a mechanism underlying the effect of ECP while in addition it can possibly serve as a reliable biomarker to objectively monitor response to ECP in patients with SS." @default.
• W3127168048 created "2021-02-15" @default.
• W3127168048 creator A5008364803 @default.
• W3127168048 creator A5011528075 @default.
• W3127168048 creator A5015431562 @default.
• W3127168048 creator A5019389886 @default.
• W3127168048 creator A5029248073 @default.
• W3127168048 creator A5048991125 @default.
• W3127168048 creator A5071547266 @default.
• W3127168048 creator A5087903302 @default.
• W3127168048 creator A5090900329 @default.
• W3127168048 creator A5091733870 @default.
• W3127168048 date "2021-01-01" @default.
• W3127168048 modified "2023-10-18" @default.
• W3127168048 title "Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome" @default.
• W3127168048 cites W2008459543 @default.
• W3127168048 cites W2096850086 @default.
• W3127168048 cites W2128184693 @default.
• W3127168048 cites W2171010115 @default.
• W3127168048 cites W2312229826 @default.
• W3127168048 cites W2415166681 @default.
• W3127168048 cites W2591481840 @default.
• W3127168048 cites W2601178524 @default.
• W3127168048 cites W2734342691 @default.
• W3127168048 cites W2743722866 @default.
• W3127168048 cites W2890499629 @default.
• W3127168048 cites W2893877319 @default.
• W3127168048 cites W2893891610 @default.
• W3127168048 cites W2909964376 @default.
• W3127168048 cites W2924559009 @default.
• W3127168048 cites W2930008898 @default.
• W3127168048 cites W2943404462 @default.
• W3127168048 cites W2998924590 @default.
• W3127168048 cites W3010935687 @default.
• W3127168048 cites W3045231193 @default.
• W3127168048 cites W3088766896 @default.
• W3127168048 doi "https://doi.org/10.1080/2162402x.2021.1873530" @default.
• W3127168048 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7872039" @default.
• W3127168048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33643690" @default.
• W3127168048 hasPublicationYear "2021" @default.
• W3127168048 type Work @default.
• W3127168048 sameAs 3127168048 @default.
• W3127168048 citedByCount "4" @default.
• W3127168048 countsByYear W31271680482021 @default.
• W3127168048 countsByYear W31271680482023 @default.
• W3127168048 crossrefType "journal-article" @default.
• W3127168048 hasAuthorship W3127168048A5008364803 @default.
• W3127168048 hasAuthorship W3127168048A5011528075 @default.
• W3127168048 hasAuthorship W3127168048A5015431562 @default.
• W3127168048 hasAuthorship W3127168048A5019389886 @default.
• W3127168048 hasAuthorship W3127168048A5029248073 @default.
• W3127168048 hasAuthorship W3127168048A5048991125 @default.
• W3127168048 hasAuthorship W3127168048A5071547266 @default.
• W3127168048 hasAuthorship W3127168048A5087903302 @default.
• W3127168048 hasAuthorship W3127168048A5090900329 @default.
• W3127168048 hasAuthorship W3127168048A5091733870 @default.
• W3127168048 hasBestOaLocation W31271680481 @default.
• W3127168048 hasConcept C126322002 @default.
• W3127168048 hasConcept C137061746 @default.
• W3127168048 hasConcept C143998085 @default.
• W3127168048 hasConcept C159654299 @default.
• W3127168048 hasConcept C202751555 @default.
• W3127168048 hasConcept C203014093 @default.
• W3127168048 hasConcept C2776780870 @default.
• W3127168048 hasConcept C2777756187 @default.
• W3127168048 hasConcept C2779134260 @default.
• W3127168048 hasConcept C2779338263 @default.
• W3127168048 hasConcept C2779972918 @default.
• W3127168048 hasConcept C2781468836 @default.
• W3127168048 hasConcept C2909962264 @default.
• W3127168048 hasConcept C40677261 @default.
• W3127168048 hasConcept C542903549 @default.
• W3127168048 hasConcept C55493867 @default.
• W3127168048 hasConcept C71924100 @default.
• W3127168048 hasConcept C86803240 @default.
• W3127168048 hasConceptScore W3127168048C126322002 @default.
• W3127168048 hasConceptScore W3127168048C137061746 @default.
• W3127168048 hasConceptScore W3127168048C143998085 @default.
• W3127168048 hasConceptScore W3127168048C159654299 @default.
• W3127168048 hasConceptScore W3127168048C202751555 @default.
• W3127168048 hasConceptScore W3127168048C203014093 @default.
• W3127168048 hasConceptScore W3127168048C2776780870 @default.
• W3127168048 hasConceptScore W3127168048C2777756187 @default.
• W3127168048 hasConceptScore W3127168048C2779134260 @default.
• W3127168048 hasConceptScore W3127168048C2779338263 @default.
• W3127168048 hasConceptScore W3127168048C2779972918 @default.
• W3127168048 hasConceptScore W3127168048C2781468836 @default.
• W3127168048 hasConceptScore W3127168048C2909962264 @default.
• W3127168048 hasConceptScore W3127168048C40677261 @default.
• W3127168048 hasConceptScore W3127168048C542903549 @default.
• W3127168048 hasConceptScore W3127168048C55493867 @default.
• W3127168048 hasConceptScore W3127168048C71924100 @default.
• W3127168048 hasConceptScore W3127168048C86803240 @default.
• W3127168048 hasFunder F4320307844 @default.
• W3127168048 hasFunder F4320320924 @default.
• W3127168048 hasIssue "1" @default.
• W3127168048 hasLocation W31271680481 @default.
• W3127168048 hasLocation W31271680482 @default.
• W3127168048 hasLocation W31271680483 @default.
• W3127168048 hasLocation W31271680484 @default.

• next